prostate%20cancer
PROSTATE CANCER

Prostate cancer is the cancer that occurs in the male's prostate.

It is the most common cancer in men >50 years of age.

Signs and symptoms include weak urinary stream, polyuria, nocturia, hematuria, erectile dysfunction, pelvic pain, back pain, chest pain, lower extremity weakness or numbness and loss of bowel or bladder control.

Prostate Cancer Drug Information

Drug Information

Indication: Monotherapy or combination therapy for palliative treatment of metastatic non-seminomatous germ cell carcinoma...

Indication: Monotherapy for metastatic breast cancer. Advanced ovarian cancer in women who have failed 1st-line platinum-b...

Indication: Locally advanced or metastatic breast cancer after failure of previous therapy. In combination w/ doxorubicin ...

Indication: Breast, gastric, ovarian & small cell lung cancer; non-Hodgkin's lymphoma; advanced/metastatic soft tissue...

Indication: Metastatic breast cancer. Advanced ovarian cancer in women who have failed a 1st-line platinum based chemother...

Indication: Monotherapy for maintenance treatment of adult patients w/ platinum-sensitive relapsed BRCA-mutated (germline ...

Indication: Hypercalcemia of malignancy. Prevention of skeletal-related events (pathological fractures, spinal compression...

Indication: Breast, gastric, ovarian, small cell lung & superficial bladder (Tis, Ta) cancer, Non-Hodgkin's lymphoma, ...

Indication: Metastatic non-seminomatous germ cell carcinoma. Advanced stage, refractory ovarian & bladder carcinoma. R...

Indication: Moderate to severe vasomotor symptoms associated w/ estrogen deficiency. Prevention & management of osteop...

2  /  7
Editor's Recommendations
Most Read Articles
2 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
2 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Tristan Manalac, 6 days ago
The substitution of isoleucine to leucine at amino acid 97 (I97L) in the core region of the hepatitis B virus (HBV) seems to reduce its potency, decreasing the efficiency of both infection and the synthesis of the virus’ covalently closed circular (ccc) DNA, reports a new study presented at The Liver Meeting Digital Experience by the American Association for the Study of Liver Diseases (AASLD 2020).